RECRU is a collaborative group of McGill and RI-MUHC scientists within the Translational Research in Respiratory Diseases (RESP) Program whose work advances respiratory clinical, translational, epidemiological, and health services research. Members contribute to a collaborative research environment that supports scientific exchange, mentorship, and trainee development.
|
|
Dr Faiz Ahmad Khan, MD, MPH, FRCP(c)
Tuberculosis, global and Indigenous health, respiratory epidemiology, implementation research, and strategies to improve tuberculosis diagnosis and management.
View RI-MUHC profile.
|
 |
Deborah Assayag, MD, MAS
Interstitial lung disease, pulmonary fibrosis, autoimmunity, epidemiology, prognosis, and disparities and delays in care
View RI-MUHC profile.
|
|
|
Andrea Benedetti, PhD
Biostatistics and epidemiology, including statistical methods for individual participant data meta-analyses, longitudinal and clustered data, and respiratory health research.
View RI-MUHC profile.
|
|
|
Jean Bourbeau, MD, MSc, FRCPC
COPD epidemiology and outcomes, integrated care and self-management, pulmonary rehabilitation, and population-based COPD research.
View RI-MUHC profile.
|
 |
Jonathon Campbell, PhD
Tuberculosis prevention and care, infectious diseases, economic evaluation, implementation of public health strategies, and health system and patient costs.
View RI-MUHC profile.
|
 |
Nermin Diab, MD
COPD, asthma, and clinical trials in obstructive lung disease.
View RI-MUHC profile.
|
 |
Nicole Ezer, MD
Lung cancer screening and epidemiology, comparative effectiveness, outcomes research, health disparities, and applications of artificial intelligence to health data.
View RI-MUHC profile.
|
|
|
Anne Gonzalez, MD, MSC
Lung cancer diagnosis and staging, interventional pulmonary procedures, and pleural disease.
View RI-MUHC profile.
|
 |
Tania Janaudis-Ferreira, PhD
Physical rehabilitation, COPD, pulmonary rehabilitation, transplantation, clinical research, implementation, and knowledge translation.
View RI-MUHC profile.
|
|
|
Dennis Jensen, PhD
Clinical exercise and respiratory physiology, mechanisms of exertional dyspnea and exercise intolerance, and chronic cardiorespiratory disease, particularly COPD.
View RI-MUHC profile.
|
|
|
Marta Kaminska MD, MSc, FRCP(C)
Sleep-disordered breathing, obstructive sleep apnea, neurological and neuromuscular disorders, and long-term non-invasive ventilation.
View RI-MUHC profile.
|
|
|
R. John Kimoff, MD
Sleep apnea and sleep-disordered breathing, with a focus on upper airway neuromuscular function, cardiometabolic outcomes, and sleep-related breathing disorders in neurological disease.
View RI-MUHC profile.
|
|
|
Dick Menzies, MD
Clinical and epidemiological research in tuberculosis, including diagnosis and treatment of tuberculosis infection and disease, drug-resistant tuberculosis, and global health.
View RI-MUHC profile.
|
|
|
Ron Olivenstein, MD
Asthma and COPD, with a focus on severe asthma, airway inflammation, bronchoscopy, clinical trials, and novel therapeutic approaches.
View RI-MUHC profile.
|
|
|
Sushmita Pamidi, MD, MS
Sleep-disordered breathing and sleep apnea, with a focus on cardiometabolic outcomes in pregnancy and the general population, biomarkers, and clinical research.
View RI-MUHC profile.
|
|
|
Bryan Ross, MD, MSc
COPD and acute exacerbations, pulmonary rehabilitation, respiratory physiology, digital health, wearable technologies, and remote patient monitoring.
View RI-MUHC profile.
|
|
|
Kevin Schwartzman, MD, MPH, FRCPC
Tuberculosis epidemiology and prevention, public health, health economics, cost-effectiveness and decision modelling, and digital adherence technologies.
View RI-MUHC profile.
|
|
|
Benjamin M. Smith, MD, MSc
Obstructive lung diseases, COPD, with a focus on lung structure, advanced imaging, cardiopulmonary physiology, and population-based epidemiology.
View RI-MUHC profile.
|
